22Dec
Cadent Therapeutics Acquired by Novartis for Up to $770 Million
Cadent Therapeutics, a Cambridge, Massachusetts-based, privately held clinical stage biopharmaceutical company focused on the development of therapies for the treatment of cognitive, mood, and movement disorders, announced on December 17, 2020, that Novartis will acquire all of the outstanding capital stock of Cadent Therapeutics....
By:
Rothwell, Figg, Ernst & Manbeck, P.C.
Related
A question often asked by employers in the United Kingdom that are facing a strike or other forms of...
Read More >
On the heels of the U.S. Women’s Soccer Team’s World Cup win, Governor Andrew Cuomo on July 10, 20...
Read More >
On June 3, 2019, the U.S. Supreme Court ruled that the charge filing requirement under Title VII of ...
Read More >
In 2014, the Obama-era National Labor Relations Board made over two dozen changes to the union elect...
Read More >
Since its advent more than 30 years ago, the 3D printing market has grown, and will continue to expa...
Read More >
While bargaining, unions often demand that employers produce information relevant to the bargaining ...
Read More >